VICL.n ($3.65) Vical-VICL files NDA in Japan for Collategene Angiogenesis product
Friday, March 28 2008 - 6:32
VICL $3.65 $0.32 (%9.61)
<org>Vical Incorporated announced the company's licensee, AnGes MG, Inc., reported submission on March 27, 2008, of a New Drug Application to the Japanese Ministry of Health, Labor and Welfare for its angiogenesis product candidate, Collategene, for treatment of critical limb ischemia. The treatment uses Vical technology to deliver a gene encoding hepatocyte growth factor, a human protein that causes growth of blood vessels in areas of restricted blood flow.
Market Data 
Markets 
AI
